Impact of a Disease-Associated Dynactin Variant on Motile Phenomena in Lung Epithelial Cells
疾病相关的 Dynactin 变体对肺上皮细胞运动现象的影响
基本信息
- 批准号:10704306
- 负责人:
- 金额:$ 36.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcute Respiratory Distress SyndromeAffectBehaviorBindingBiochemicalBiochemistryBiological AssayBiosensorBiotinylationCell AdhesionCell membraneCell physiologyCell surfaceCellsCellular biologyCharacteristicsComplementCoupledCuesCystic FibrosisCytoskeletonDataDefectDetectionDiseaseDisease ProgressionDynein ATPaseEpithelialEpithelial CellsEventFibrosisFocal Adhesion Kinase 1Focal AdhesionsGenesGeneticGenetic TranscriptionGoalsGuanineGuanine Nucleotide Exchange FactorsHumanHuman Cell LineImageIntegrinsLeadLinkLungLung AdenocarcinomaLung diseasesMaintenanceMembraneMesenchymeMethodsMicroscopyMicrotubulesMitosisMotorMovementPathologyPhasePhenotypePlus End of the MicrotubulePositioning AttributeProcessProteinsProteomeProteomicsPulmonary PathologyReceptor Protein-Tyrosine KinasesRiskRoleSecretory VesiclesSepsisSignal PathwaySignal TransductionSorting - Cell MovementSurfaceTotal Internal Reflection FluorescentTransitional EpitheliumVariantWorkassaultbasebronchial epitheliumcell cortexcell motilitycofactorcohortcontrast imagingcrosslinkcytokinedynactinephexinexome sequencingexperimental studyimaging studyin vivoinsightinterestlung repairmacromolecular assemblymigrationmonolayernovelprotein transportrepairedresponserho GTP-Binding Proteinsstemtooltraffickingtumorwoundwound healing
项目摘要
Project Summary
The microtubule-based motor, cytoplasmic dynein-1, is best known for providing motile functions in
membrane trafficking and mitosis. Complete abrogation of dynein function yields gross cellular and
organismal defects that preclude detection of its contributions to other important cellular phenomena. The
work described in this proposal focuses on a human dynein variant, DCTN4Y270C, that is associated with
increased risk of extreme lung pathology. DCTN4Y270C (rs35772018) was first identified as a genetic
modifier of cystic fibrosis but has also been associated with increased risk of lung adenocarcinoma and
acute respiratory distress syndrome following sepsis. Homozygous DCTN4Y270C has no obvious impact on
its own, indicating that any defects associated with DCTN4Y270C exacerbate pathology but do not cause it
directly.
Lung epithelial cells must be able to undergo a reversible epithelial-mesenchyme transition (EMT) to
provide the ongoing wound-healing that is required for repair and maintenance of the airway. Imbalance in
reversible EMT is believed to underlie the fibrosis seen in severe lung disease. Phenotypically, DCTN4Y270C
expression yields reduced cell movement into experimental wounds and facilitates acquisition of epithelial
polarity, both hallmarks of the mesenchyme-epithelial transition (MET). Transcriptionally, cultured
bronchial epithelial cells expressing DCTN4Y270C show with hallmarks characteristic of EMT. These
incongruent findings indicate that DCTN4Y270C positions cells in an aberrant, yet tolerated, state that lies
between epithelia and mesenchyme, similar to the partial EMT seen in tumors. The overarching goal of the
proposed work is to understand how DCTN4Y270C affects lung cell biology, specifically the cytoskeleton-
dependent phenomena that underlie directed cell migration.
To obtain mechanistic insight into how DCTN4Y270C alters cell function we determined the interactomes of
DCTN4WT and DCTN4Y270C using BioID proximity biotinylation. This revealed a small cohort of differential
interactors that others have linked to the phenomena we know to be altered in cells expressing
DCTN4Y270C. The aims of this project are to establish mechanistic connections between dynein/dynactin
and these novel interactors, taking advantage of DCTN4Y270C as a unique tool for modulating and
perturbing cell function.
项目摘要
基于微管的马达,细胞质动力蛋白-1,最为人所知的是提供运动功能
膜运输和有丝分裂。完全取消动力蛋白功能会产生大量的细胞和
器官缺陷,使人们无法检测到它对其他重要细胞现象的贡献。这个
该提案中描述的工作重点是人类动力蛋白变异体DCTN4Y270C,它与
增加了极端肺部病变的风险。DCTN4Y270C(Rs35772018)首次被鉴定为遗传性
囊性纤维化的修饰物,但也与肺腺癌和
脓毒症后的急性呼吸窘迫综合征。纯合子DCTN4Y270C对
它本身,表明任何与DCTN4Y270C相关的缺陷都会加剧病理,但不会导致病理
直接去吧。
肺上皮细胞必须能够经历可逆的上皮-间充质转化(EMT)
提供修复和维持呼吸道所需的持续伤口愈合。不平衡
可逆性EMT被认为是严重肺部疾病所见纤维化的基础。表型:DCTN4Y270C
表达减少了细胞在实验创面中的移动,并促进了上皮细胞的获得
极性,这两个标志间充质-上皮转化(MET)。转录上,培养的
表达DCTN4Y270C的支气管上皮细胞具有EMT的特征。这些
不一致的发现表明,DCTN4Y270C将细胞定位在一种异常的、但仍可耐受的状态
位于上皮和间质之间,类似于肿瘤中的部分EMT。的首要目标是
拟议的工作是了解DCTN4Y270C如何影响肺细胞生物学,特别是细胞骨架-
细胞定向迁移背后的依赖现象。
为了深入了解DCTN4Y270C如何改变细胞功能,我们确定了
DCTN4WT和DCTN4Y270C使用BioID邻近生物素化。这揭示了一小群不同的
其他人已经将其与我们已知的在细胞中表达的改变的现象联系起来的相互作用
DCTN4Y270C。这个项目的目的是在动力蛋白/动力蛋白之间建立机械联系。
和这些新型的互感器,利用DCTN4Y270C作为一种独特的工具来调制和
扰乱细胞功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRINA A SCHROER其他文献
TRINA A SCHROER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRINA A SCHROER', 18)}}的其他基金
REGULATION OF CYTOPLASMIC DYNEIN BASED VESICLE TRANSPORT
基于细胞质动力蛋白的囊泡运输的调节
- 批准号:
8171285 - 财政年份:2010
- 资助金额:
$ 36.69万 - 项目类别:
REGULATION OF CYTOPLASMIC DYNEIN BASED VESICLE TRANSPORT
基于细胞质动力蛋白的囊泡运输的调节
- 批准号:
7957806 - 财政年份:2009
- 资助金额:
$ 36.69万 - 项目类别:
REGULATION OF CYTOPLASMIC DYNEIN BASED VESICLE TRANSPORT
基于细胞质动力蛋白的囊泡运输的调节
- 批准号:
7723664 - 财政年份:2008
- 资助金额:
$ 36.69万 - 项目类别:
Molecular mechanism of SIF formation by Salmonella Typhimurium
鼠伤寒沙门氏菌形成SIF的分子机制
- 批准号:
7197072 - 财政年份:2007
- 资助金额:
$ 36.69万 - 项目类别:
Molecular mechanism of SIF formation by Salmonella Typhimurium
鼠伤寒沙门氏菌形成SIF的分子机制
- 批准号:
7339653 - 财政年份:2007
- 资助金额:
$ 36.69万 - 项目类别:
MICROTUBULE BASED VESICLE TRANSPORT IN POLARIZED EPITHELIA
极化上皮中基于微管的囊泡运输
- 批准号:
6564275 - 财政年份:2002
- 资助金额:
$ 36.69万 - 项目类别:
MICROTUBULE BASED VESICLE TRANSPORT IN POLARIZED EPITHELIA
极化上皮中基于微管的囊泡运输
- 批准号:
6410323 - 财政年份:2001
- 资助金额:
$ 36.69万 - 项目类别:
MICROTUBULE BASED VESICLE TRANSPORT IN POLARIZED EPITHELIA
极化上皮中基于微管的囊泡运输
- 批准号:
6301128 - 财政年份:2000
- 资助金额:
$ 36.69万 - 项目类别:
MICROTUBULE BASED VESICLE TRANSPORT IN POLARIZED EPITHELIA
极化上皮中基于微管的囊泡运输
- 批准号:
6105498 - 财政年份:1999
- 资助金额:
$ 36.69万 - 项目类别:
MICROTUBULE BASED VESICLE TRANSPORT IN POLARIZED EPITHELIA
极化上皮中基于微管的囊泡运输
- 批准号:
6270727 - 财政年份:1998
- 资助金额:
$ 36.69万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 36.69万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 36.69万 - 项目类别:














{{item.name}}会员




